Hi, what are you looking for?
Jewish Business News
Search results for "perrigo"
Business
Regulator tells Migdal Insurance to rescind giant dividend; Noble Energy posts wider-than-expected loss for the third quarter; Pharma, telecom shares lead Tel Aviv higher.
Business
Court rules that Mylan provided adequate public disclosures.
Business
6% workforce reduction, $2 billion in stock repurchases and vitamin unit sale in the offing
Business
The hostile takeover bid for Perrigo Co. PLC continues with Mylan NV hosting a Tuesday, 5 pm, conference call to pitch the buyout...
Business
The Generic-drug maker took its bid directly to shareholders after being rebuffed since April
Business
Trying to fend off a hostile takeover attempt by Mylan’s $27 billion bid, Perrigo Chairman, President and CEO Joseph Papa sent a letter...
Business
Mylan N.V. (NASDAQ: MYL) shareholders have approved Mylan’s proposed acquisition of Perrigo Company plc (NYSE: PRGO; TASE). The transaction received the approval of two-thirds of...
Business
Joseph Papa scathingly dismisses Mylan's latest tactic in lowering the stake it wants to buy in Perrigo. "today's announcement makes it even worse"
Business
Mylan could settle for buying control of Perrigo, rather than full ownership, keeping Perrigo listed on the TASE.
Business
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Erez Vigodman said today, “If the Mylan Pharmaceuticals shareholders support the acquisition of...